Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5344-5347

  Reichert, Torsten E ^a   Day, Roger ^b,d   Wagner, Eva M ^a   Whiteside, Theresa L ^c,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE;

ADULT; AGED; ARTICLE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 0032403180     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613-5616, 1993.
2. Zea, A. H., Brendan, C. D., Longo, D. L., Alvord, W. G., Strobl, S. L., Mizoguchi, H., Creekmore, S. P., O'Shea, J. J., Powers, G. C., Urba, W. J., and Ochoa, A. C. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res., 1: 1327-1335, 1995.
3. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J-L., Vivier, E., Anderson, P., and Kiessling, R. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610-5612, 1993.
4. Lai, P., Rabinowich, H., Crowley-Nowick, P. A., Bell, M. C., Mantovani, G., and Whiteside, T. L. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res., 2: 161-173, 1996.
5. Rabinowich, H., Suminami, Y., Reichert, T. E., Crowley-Nowick, P., Bell, M., Edwards, R., and Whiteside, T. L. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int. J. Cancer, 68: 276-284, 1996.
6. Whiteside, T. L., and Rabinowich, H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol. Immunother., 46: 175-184, 1998.
7. Buggins, A. G. S., Hirst, W. J. R., Pagliuca, A., and Mufti, G. J. Variable expression of CD3-46 and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies. Br. J. Haematol., 100: 784-792, 1998.
8. Kono, K., Ressing, M. E., Brandt, R. M. P., Melief, C. J. M., Potkul, R. K., Andersson, B., Petersson, M., Kast, W. M., and Kiessling, R. Decreased expression of signal-tranducing 46 chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin. Cancer Res., 2: 1825-1828, 1996.
9. Healy, C. G., Simons, J. W., Carducci, M. A., DeWeese, T. L., Bartkowski, M., Tong, K. P., and Bolton, W. E. Impaired expression and function of signal-transducing ζ chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry, 32: 109-119, 1998.
10. Reichert, T. E., Rabinowich, H., Johnson, J. T., and Whiteside, T. L. Human immune cells in the tumor microenvironment: mechanism responsible for signaling and functional defects. J. Immunother., 21: 295-306, 1998.
11. Rabinowich, H., Reichert, T. E., Kashii, Y., Bell, M. C., and Whiteside, T. L. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: implications for altered expression of TcR in tumor-associated lymphocytes. J. Clin. Invest., 101: 2579-2588, 1998.
12. Aoe, T., Okamoto, Y., and Saito, T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med., 181: 1881-1886, 1995.
13. Battifora, H. Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am. J. Pathol., 96: 669-671, 1991.
14. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., and Ochoa, A. C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795-1797, 1992.
15. Correa, M. R., Ochoa, A. C., Ghosh, P., Mizoguchi, H., Harvey, L., and Longo, D. L. Sequential development of structural and functional alterations in T cells from tumor-bearing mice. J. Immunol., 158: 5292-5296, 1997.
16. fγn, ZAP-70, and CD3ζ despite suppressed cytolytic activity. J. Exp. Med., 182: 1029-1036, 1995.
17. Cardi, G., Heaney, J. A., Schned, A. R., Phillips, D. M., Branda, M. T., and Ernstoff, M. S. T-cell receptor ζ chain expression on tumor infiltrating lymphocytes from renal cell carcinoma. Cancer Res., 57: 3517-3519, 1998.
18. Kono, K., Salazar-Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., and Kiessling, R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell and natural killer cell-mediated cytotoxicity. Eur. J. Immunol., 26: 1308-1313, 1996.
19. + T cells. J. Immunol., 149: 949-956, 1992.
20. Irving, B. A., and Weiss, A. The cytoplasmic domain of the T cell receptor 46 chain is sufficient to couple to receptor-associated signal transduction pathways. Cell, 64: 891-901, 1991.
21. Ghosh, P., Komschlies, K. L., Cippitelli, M., Longo, D. L., Subleski, J., Ye, J., Sica, A., Young, H. A., Wiltrout, R. H., and Ochoa, A. C. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. Natl. Cancer Inst. (Bethesda), 87: 1478-1483, 1995.
22. Rabinowich, H., Banks, M., Reichert, T. E., Logan, T. F., Kirkwood, J. M., and Whiteside, T. L. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin-2 therapy. Clin. Cancer Res., 2: 1263-1272, 1996.
23. Ravi, R., Bedi, A., Fuchs, E. J., and Bedi, A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res., 58: 882-886, 1998.